Clostridium Difficile Clinical Trials

3 recruiting

Clostridium Difficile Trials at a Glance

16 actively recruiting trials for clostridium difficile are listed on ClinicalTrialsFinder across 6 cities in 26 countries. The largest study group is Not Applicable with 4 trials, with the heaviest enrollment activity in Houston, Detroit, and Ann Arbor. Lead sponsors running clostridium difficile studies include American Gastroenterological Association, Assistance Publique - Hôpitaux de Paris, and ABResearch S.r.l..

Browse clostridium difficile trials by phase

Treatments under study

About Clostridium Difficile Clinical Trials

Looking for clinical trials for Clostridium Difficile? There are currently 3 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Clostridium Difficile trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Clostridium Difficile clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 116 of 16 trials

Recruiting
Phase 3

VE303 for Prevention of Recurrent Clostridioides Difficile Infection

Clostridium Difficile Infection RecurrenceClostridium DifficileClostridioides Difficile Infection+7 more
Vedanta Biosciences, Inc.852 enrolled215 locationsNCT06237452
Recruiting
Phase 1Phase 2

FMT in Patients With Recurrent CDI and Ulcerative Colitis: Single Infusion Versus Sequential Approach

Ulcerative ColitisClostridium Difficile
Fondazione Policlinico Universitario Agostino Gemelli IRCCS64 enrolled1 locationNCT06071312
Recruiting

Clostridioides Difficile Infection: Analyzing CLInic Evolution and Bacterial Clearance

Clostridium Difficile Infections
Fondation Hôpital Saint-Joseph100 enrolled1 locationNCT06030245
Recruiting
Not Applicable

Outcomes and Data Collection for Fecal Microbiota Transplantation for the Treatment of Recurrent Clostridium Difficile

Clostridium Difficile InfectionClostridium Difficile Infection Recurrence
Krunal Patel500 enrolled1 locationNCT03562741
Recruiting

Fecal Microbiota Transplant National Registry

Fecal Microbiota TransplantationGut MicrobiomeClostridium Difficile Infection
American Gastroenterological Association4,000 enrolled53 locationsNCT03325855
Recruiting

Real-World Study on Fecal Microbiota Transplantation: Long-Term Effectiveness and Safety Statistics

Ulcerative Colitis (UC)Crohn Disease (CD)Autism Spectrum Disorder+6 more
Chen QiYi4,000 enrolled1 locationNCT07261826
Recruiting
Phase 2Phase 3

Enteral Vancomycin as Primary Prophylaxis Against Clostridioides Difficile Infection in Critically Ill Patients

Clostridium Difficile InfectionVancomycin Resistant Enterococci Infection
Riverside University Health System Medical Center176 enrolled1 locationNCT07221370
Recruiting
Phase 2

Stool Transplants to Treat Refractory Clostridium Difficile Colitis

Clostridium Difficile Colitis
Duke University77 enrolled1 locationNCT02127398
Recruiting

Safety Registry of a Fecal Microbiota Transplant Cohort

Clostridium Difficile Infections
Assistance Publique - Hôpitaux de Paris305 enrolled1 locationNCT06311006
Recruiting
Not Applicable

Fecal Microbiota Transplantation for C Diff Infection

Clostridium Difficile Infection
Englewood Hospital and Medical Center100 enrolled1 locationNCT01905709
Recruiting
Not Applicable

Advantages and Disadvantages of TOXCLEAN As Add on Treatment to SOC in Patients with Clostridium Difficile-associated Diarrhea

Clostridium Difficile DiarrheaClostridium; Difficile, As Cause of Disease Classified Elsewhere
ABResearch S.r.l.18 enrolled1 locationNCT06839209
Recruiting

Study on Clostridium Difficile Infection in Infants

Clostridium Difficile Infection
First People's Hospital of Hangzhou150 enrolled1 locationNCT06703918
Recruiting
Phase 2

Alanyl-glutamine Supplementation for C. Difficile Treatment (ACT)

Clostridium Difficile InfectionClostridioides Difficile InfectionClostridium Difficile Diarrhea+1 more
University of Virginia260 enrolled2 locationsNCT04305769
Recruiting
Not Applicable

Safety and Efficacy of Fecal Microbiota Transplantation

AlopeciaDiabetes MellitusObesity+18 more
Chinese University of Hong Kong450 enrolled1 locationNCT04014413
Recruiting

Dynamics of Colonization and Infection by Multidrug-Resistant Pathogens in Immunocompromised and Critically Ill Patients

Antibiotic Resistant InfectionCarbapenem-Resistant Enterobacteriaceae InfectionVancomycin Resistant Enterococci Infection+5 more
The Methodist Hospital Research Institute1,000 enrolled2 locationsNCT06258551
Recruiting

The efficacy and safety of faecal microbiota transplantation for recurrent or relapsing Clostridium difficile in Western Australia

Recurrent or relapsing Clostridium difficile infection
Fiona Stanley Fremantle Hospital Group50 enrolled2 locationsACTRN12615001220550